Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of California, San Francisco
About this trial
The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with 'come-and-go'/paroxysmal AFib. The question it aims to answer is:
Is there a greater occurrence of AFib episodes when participants are allowed to consume alcohol according to random assignment?
Participants will:
* Be given daily random assignments to avoid or not to avoid alcohol * Wear an adhesive electrocardiographic (ECG) heart monitor * Wear a wrist-worn fitness tracker * Wear an anklet transdermal alcohol monitor * Wear an adhesive glucose monitor * Complete morning and evening surveys daily
Participants may be compensated up to $50 for full completion of the study. This study can be done in-person or remote.
Eligibility criteria
Qualifiers
Comfortable reading and writing in English
Have a smartphone and willing and able to use the Eureka mobile application
Currently diagnosed with paroxysmal AFib without a plan to change their AFib management during the two-week monitoring period
At least one episode of AFib in the past month OR, in the judgement of a healthcare provider, could potentially have one episode of AF in the next month
Disqualifiers
Only post-operative AFib
Greater than 40% ventricular pacing
History of alcohol addiction or abuse determined by self-reported history or AUDIT-C score
Intolerance to alcohol
Trial design
Treatments tested in this trial
- Alcohol Consumption Randomized Instructions
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, San Francisco
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Source ClinicalTrials.gov